Table 1. Baseline characteristics of the... | American Society of Hematology

Table 1.

Baseline characteristics of the patients

	Arm A; n = 200	Arm B; n = 196	Arm C; n = 201
Sex, M/F, no. of patients	110/90	109/87	112/89
Age, y	59 ± 8*	59 ± 8	58 ± 8
DS stage I/II/III, no. of patients	19/50/131	16/34/146	16/42/143
M component, no. of patients
IgG	124	129	119
IgA	47	32	52
Bence Jones	24	30	28
IgD	5	5	2
Hemoglobin, g/dL	11.3 ± 2	11.2 ± 2	11.1 ± 2
Serum calcium, μM	2.4 ± 0.2	2.4 ± 0.3	2.4 ± 0.4
Serum albumin, g/L	40 ± 7	40 ± 8	39 ± 7
Lactate dehydrogenase, IU	321 ± 146	336 ± 146	311 ± 143
Serum creatinine, μM	101 ± 64	101 ± 67	101 ± 57
Bone marrow plasmocytosis, % of cells	30 ± 24	34 ± 24	31 ± 25
Serum β-2 microglobulin, mg/L	3.4 ± 3	3.3 ± 2.5	3.7 ± 5
C reactive protein, mg/L	10 ± 16	10 ± 18	11 ± 23
Chromosome 13, no. of patients
No deletion	134	136	142
Deletion	60	56	55
Unknown	6	4	4

	Arm A; n = 200	Arm B; n = 196	Arm C; n = 201
Sex, M/F, no. of patients	110/90	109/87	112/89
Age, y	59 ± 8*	59 ± 8	58 ± 8
DS stage I/II/III, no. of patients	19/50/131	16/34/146	16/42/143
M component, no. of patients
IgG	124	129	119
IgA	47	32	52
Bence Jones	24	30	28
IgD	5	5	2
Hemoglobin, g/dL	11.3 ± 2	11.2 ± 2	11.1 ± 2
Serum calcium, μM	2.4 ± 0.2	2.4 ± 0.3	2.4 ± 0.4
Serum albumin, g/L	40 ± 7	40 ± 8	39 ± 7
Lactate dehydrogenase, IU	321 ± 146	336 ± 146	311 ± 143
Serum creatinine, μM	101 ± 64	101 ± 67	101 ± 57
Bone marrow plasmocytosis, % of cells	30 ± 24	34 ± 24	31 ± 25
Serum β-2 microglobulin, mg/L	3.4 ± 3	3.3 ± 2.5	3.7 ± 5
C reactive protein, mg/L	10 ± 16	10 ± 18	11 ± 23
Chromosome 13, no. of patients
No deletion	134	136	142
Deletion	60	56	55
Unknown	6	4	4

All such values are means ± SD.